Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details)

v3.21.2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE (Details) - shares
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Conversion of Series B Preferred Stock [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 9,431,250  
Conversion Of Series E 1 Preferred Stock [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 8,500,000  
Common Stock Options [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 1,112,619 468,619
Common Stock Warrants [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 7,559,289 46,154
Conversion of Debentures [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 218,750 66,000
Conversion of Debentures [Member] | Shares May Be Converted into Bridge Notes [Member]    
Antidilutive securities excluded from computation of net loss per share, amount   8,079,617
Conversion of Redeemable Convertible Preferred Stock [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 4,286,875 3,522,591